Stryker Corporation, a global medical technology company, is gearing up to announce its fiscal fourth-quarter earnings. Analysts expect a profit of $4.39 per share, reflecting a 9.5% increase from the year-ago quarter. For the full year, EPS is anticipated to rise by 11.2% to $13.56. The stock has declined by 4.3% over the past year, underperforming the S&P 500 Index’s gains. However, shares rose more than 1% after an upgrade by Citizens JMP Securities. Analysts are reasonably bullish on SYK stock, with a consensus rating of “Strong Buy” and an average price target of $432.88, suggesting a potential upside of 22%.

Read more at Barchart: Stryker Earnings Preview: What to Expect